Use of botulinum toxin A for drug-refractory trigeminal neuralgia: preliminary report.

@article{Bohluli2011UseOB,
  title={Use of botulinum toxin A for drug-refractory trigeminal neuralgia: preliminary report.},
  author={Behnam Bohluli and Mohammad Hosein Kalantar Motamedi and Shahrokh C Bagheri and Mohammad Bayat and Eshagh Lassemi and Fina Navi and Nima Moharamnejad},
  journal={Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics},
  year={2011},
  volume={111 1},
  pages={47-50}
}
OBJECTIVE Botulinum toxin type A (BTX-A) has been used to treat migraine and occipital neuralgia. We report preliminary results of an ongoing study that assesses the efficacy of BTX-A on trigeminal neuralgia (TN) patients refractory to medical treatment. STUDY DESIGN We treated 15 patients (8 men and 7 women) between 28 and 67 years of age who were suffering from drug-refractory TN from February 2008 to January 2010. Symptoms, including pain duration, provoking factors, affected nerve branch… CONTINUE READING
35 Citations
12 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 35 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 12 references

Similar Papers

Loading similar papers…